FLOWCARDIA
FlowCardia, Inc. is a medical device company founded in 2002 to design and develop a portfolio of innovative, catheter-based technologies to facilitate guidewire crossing of totally occluded coronary and peripheral arteries. Chronic Total Occlusions (CTOs) are considered one of the last major clinical challenges in interventional therapy. The historic absence of safe and effective CTO recanalization devices is a major reason a large number of patients are still referred to coronary and peripheral bypass surgery and lower limb amputation.
FLOWCARDIA
Social Links:
Industry:
Biotechnology Health Care Medical Device Therapeutics
Founded:
2002-01-01
Address:
Sunnyvale, California, United States
Country:
United States
Website Url:
http://www.flowcardia.com
Total Employee:
1+
Status:
Active
Contact:
408-617–0352
Email Addresses:
[email protected]
Total Funding:
42.02 M USD
Technology used in webpage:
Liquid Web
Similar Organizations
ALung Technologies
ALung Technologies develops medical gas exchange devices for the treatment of acute and chronic respiratory disorders.
CardioProlific
CardioProlific is develops catheter-based thrombectomy approaches to treat peripheral vascular disease.
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Endovention
EndoVention designs and develops catheter technology used for the removal of blood clots.
OYS Mobility
OYS Mobility develops prosthetic technology that allows people with limb loss or deformity to access healthcare and assistive devices.
Revascular Therapeutics
Revascular Therapeutics develops solutions for the treatment of total occlusions in arteries.
Current Advisors List
Investors List
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Series C - FlowCardia
Gilde Healthcare
Gilde Healthcare investment in Series C - FlowCardia
J.P. Morgan Securities Inc.
J.P. Morgan Securities Inc. investment in Series C - FlowCardia
Gold Hill Capital
Gold Hill Capital investment in Series C - FlowCardia
New Science Ventures
New Science Ventures investment in Series C - FlowCardia
Life Sciences Partners
Life Sciences Partners investment in Series C - FlowCardia
Pappas Ventures
Pappas Ventures investment in Series C - FlowCardia
Hambrecht & Quist Capital Management
Hambrecht & Quist Capital Management investment in Series C - FlowCardia
Rockport Venture Partners
Rockport Venture Partners investment in Series C - FlowCardia
J.P. Morgan Securities Inc.
J.P. Morgan Securities Inc. investment in Series B - FlowCardia
Official Site Inspections
http://www.flowcardia.com
- Host name: 184.106.55.75
- IP address: 184.106.55.75
- Location: Lansing United States
- Latitude: 42.7348
- Longitude: -84.6245
- Metro Code: 551
- Timezone: America/Detroit
- Postal: 48917
